Literature DB >> 12057169

Desmoid tumors.

J S Biermann1.   

Abstract

Because of the wide variety of anatomic locations and patient factors, there is no one treatment that is appropriate for all desmoid tumors. The type of treatment depends on tumor characteristics and location, as well as patient characteristics and preferences. Desmoid tumors can be persistent and frustrating to manage because no one treatment modality offers a high likelihood of remission. Multiple modalities may be necessary in some patients. Although mortality is rare and is usually due to local complications, significant disability or morbidity can result from desmoid tumors, their treatment, and complications arising from treatment. The entire clinical picture and the patient's preferences must be taken into account when deciding on an appropriate treatment plan. Patients with desmoid tumors are optimally managed in a multidisciplinary setting with close collaboration between surgeon, pathologist, diagnostic radiologist, radiation oncologist, and medical oncologist. When possible, surgical resection with negative margins is the preferred modality. When surgical resection with negative margins may prove disabling, surgery can be followed by postoperative radiation, although the role and efficacy of this are controversial. In locations where surgical extirpation is difficult or unfeasible, primary radiation, hormonal therapy, or chemotherapy should be considered. Familiar adenosis polyposis (FAP)-associated mesenteric lesions, sporadic tumors present without change for months or years, or tumors present in areas where progression will not present significant additional morbidity are candidates for observation only.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12057169     DOI: 10.1007/s11864-000-0038-5

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  31 in total

1.  Interferon-induced remission in aggressive fibromatosis of the lower extremity.

Authors:  J O Fernberg; O Brosjö; O Larsson; V Söderlund; H Strander
Journal:  Acta Oncol       Date:  1999       Impact factor: 4.089

2.  Metachronous multicentric aggressive fibromatosis with mediastinal involvement.

Authors:  J M Sabaté; J A Parellada; T Franquet; J Palmer; G Peiró
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 3.  Desmoids in familial adenomatous polyposis.

Authors:  S K Clark; R K Phillips
Journal:  Br J Surg       Date:  1996-11       Impact factor: 6.939

4.  Extremity and trunk desmoid tumors: a multifactorial analysis of outcome.

Authors:  N B Merchant; J J Lewis; J M Woodruff; D H Leung; M F Brennan
Journal:  Cancer       Date:  1999-11-15       Impact factor: 6.860

Review 5.  Radiation as a therapeutic modality in sarcomas of the soft tissue.

Authors:  H Suit; I Spiro
Journal:  Hematol Oncol Clin North Am       Date:  1995-08       Impact factor: 3.722

Review 6.  Desmoid tumors.

Authors:  T Anthony; M A Rodriguez-Bigas; T K Weber; N J Petrelli
Journal:  J Am Coll Surg       Date:  1996-04       Impact factor: 6.113

7.  Therapy of desmoid tumors and fibromatosis using vinorelbine.

Authors:  A J Weiss; S Horowitz; R D Lackman; R D Lackmen
Journal:  Am J Clin Oncol       Date:  1999-04       Impact factor: 2.339

8.  Pediatric desmoid tumor: retrospective analysis of 63 cases.

Authors:  L B Faulkner; S I Hajdu; U Kher; M La Quaglia; P R Exelby; G Heller; N Wollner
Journal:  J Clin Oncol       Date:  1995-11       Impact factor: 44.544

9.  Treatment results of unresected or partially resected desmoid tumors.

Authors:  B W Goy; S P Lee; Y S Fu; M T Selch; F Eilber
Journal:  Am J Clin Oncol       Date:  1998-12       Impact factor: 2.339

10.  Combination chemotherapy in adult desmoid tumors.

Authors:  S R Patel; H L Evans; R S Benjamin
Journal:  Cancer       Date:  1993-12-01       Impact factor: 6.860

View more
  16 in total

1.  Immunohistochemical analysis of desmoid tumours.

Authors:  A Leithner; M Gapp; R Radl; A Pascher; P Krippl; K Leithner; R Windhager; A Beham
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

Review 2.  Mesenteric fibromatosis.

Authors:  Poras Chaudhary
Journal:  Int J Colorectal Dis       Date:  2014-08-21       Impact factor: 2.571

3.  Positron emission tomography in patients with aggressive fibromatosis/desmoid tumours undergoing therapy with imatinib.

Authors:  Bernd Kasper; Antonia Dimitrakopoulou-Strauss; Ludwig G Strauss; Peter Hohenberger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-19       Impact factor: 9.236

Review 4.  Desmoid tumors: clinical features and treatment options for advanced disease.

Authors:  Bernd Kasper; Philipp Ströbel; Peter Hohenberger
Journal:  Oncologist       Date:  2011-04-08

5.  Desmoid: the role of local therapy in an era of systemic options.

Authors:  Brian E Walczak; Peter S Rose
Journal:  Curr Treat Options Oncol       Date:  2013-09

6.  Spatio-temporal genetic heterogeneity of CTNNB1 mutations in sporadic desmoid type fibromatosis lesions.

Authors:  Jérôme Doyen; Valérie Duranton-Tanneur; Isabelle Hostein; Marie Karanian-Philippe; Christine Chevreau; Florence Breibach; Michael Coutts; Bérengère Dadone; Marie-Christine Saint-Paul; Jean Gugenheim; Florence Duffaud; Florence Pedeutour
Journal:  Virchows Arch       Date:  2015-12-14       Impact factor: 4.064

7.  FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin.

Authors:  David E Joyner; Sylvia H Trang; Albert J Aboulafia; Timothy A Damron; R L Randall; R Lor Randall
Journal:  Fam Cancer       Date:  2009       Impact factor: 2.375

8.  Abdominal wall desmoid tumor mimicking a subserosal uterine leiomyoma.

Authors:  Moamar Al-Jefout; Alabed Walid; Abomayale Esam; Alqaisi Amin; Hawa Nather; Nawayse Sultan; Khadra Maysa
Journal:  Int J Gen Med       Date:  2011-06-08

9.  Positron emission tomography as a surrogate marker for evaluation of treatment response in patients with desmoid tumors under therapy with imatinib.

Authors:  Bernd Kasper; Antonia Dimitrakopoulou-Strauss; Lothar R Pilz; Ludwig G Strauss; Christos Sachpekidis; Peter Hohenberger
Journal:  Biomed Res Int       Date:  2013-05-16       Impact factor: 3.411

10.  Diagnosis and treatment of extraabdominal desmoid fibromatosis.

Authors:  Mohamed Ghanem; Antje Heinisch; Christoph-E Heyde; Georg Freiherr von Salis-Soglio
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2014-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.